IGC Industries Limited (IGCIL.BO)
INR 11.78
(-5.0%)
INR 11.78
(-5.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 386 Thousand | 314.27 Thousand | 222.24 Thousand | 5.26 Million |
| Cost of Revenue | 39 Thousand | 54 Thousand | 632 Thousand | 518.93 Thousand | 155.12 Thousand | 4.87 Million |
| Gross Profit | -39 Thousand | -54 Thousand | -246 Thousand | -204.65 Thousand | 67.11 Thousand | 390.92 Thousand |
| Operating Expenses | 544 Thousand | 1.79 Million | 3.23 Million | 3 Million | 13.47 Million | 5.04 Million |
| Selling, General and Administrative Expenses | 544 Thousand | 1.63 Million | 3.23 Million | 3 Million | 1.53 Million | 1.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -160 Thousand | - | - | - | - |
| Cost and Expenses | 544 Thousand | 1.84 Million | 3.86 Million | 3.52 Million | 13.62 Million | 9.91 Million |
| Operating Income | -544 Thousand | -1.84 Million | -3.47 Million | -3.21 Million | -3.85 Million | -4.64 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 200.00 | 22 Thousand | - | 3556.00 | - | 162.7 Thousand |
| Earnings before Tax | -3.94 Million | -1.78 Million | -3.48 Million | -3.08 Million | -11.68 Million | 119.91 Thousand |
| Net Income | -3.94 Million | -1.78 Million | -3.48 Million | -3.09 Million | -11.68 Million | -42.79 Thousand |
| Earnings Per Share Basic | -1.76 | -0.80 | -1.55 | -1.38 | -5.22 | -0.02 |
| Earnings Per Share Diluted | -1.76 | -0.80 | -1.55 | -1.38 | -5.22 | -0.02 |
| Weighted Average Shares Outstanding | 2.24 Million | 2.24 Million | 2.24 Million | 2.24 Million | 2.23 Million | 2.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.24 Million | 2.24 Million | 2.24 Million | 2.24 Million | 2.24 Million | 2.24 Million |
| Gross Margin | - | - | -0.64 | -0.65 | 0.30 | 0.07 |
| EBIT Margin | - | - | -8.81 | -10.13 | -9.76 | -0.43 |
| Profit Margin | - | - | -9.02 | -9.84 | -52.57 | -0.01 |
| EBITDA | -1.52 Million | -1.79 Million | -3.39 Million | -3.05 Million | -2.16 Million | -2.27 Million |
| Earnings Before Tax Margin | - | - | -9.01 | -10.22 | -17.34 | -0.88 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 19.85 Million | - | - | - | - | - |
| Cost of Revenue | 17.06 Million | - | 39 Thousand | 12 Thousand | - | 27 Thousand |
| Gross Profit | 2.78 Million | - | -39 Thousand | -12 Thousand | - | -27 Thousand |
| Operating Expenses | 25 Thousand | 4000.00 | 3.88 Million | 108 Thousand | 3.17 Million | 58 Thousand |
| Selling, General and Administrative Expenses | 25 Thousand | 4000.00 | - | 108 Thousand | 3.17 Million | 58 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 17.08 Million | 4000.00 | 3.92 Million | 120 Thousand | 3.17 Million | 85 Thousand |
| Operating Income | 2.76 Million | -4000.00 | -3.92 Million | -120 Thousand | -3.17 Million | -85 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -9750.00 | 1000.00 | - | -13.5 Thousand | - |
| Earnings before Tax | 2.76 Million | -4000.00 | -3.94 Million | -130 Thousand | -3.17 Million | -85 Thousand |
| Net Income | 2.76 Million | -4000.00 | -3.94 Million | -130 Thousand | -3.17 Million | -85 Thousand |
| Earnings Per Share Basic | 1.23 | -0.00 | - | -0.06 | -1.42 | -0.04 |
| Earnings Per Share Diluted | 1.23 | -0.00 | - | -0.06 | -1.42 | -0.04 |
| Weighted Average Shares Outstanding | 2.24 Million | 2.24 Million | 2.24 Million | 2.16 Million | 2.24 Million | 2.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.24 Million | 2.24 Million | 2.24 Million | 2.16 Million | 2.24 Million | 2.24 Million |
| Gross Margin | 0.14 | - | - | - | - | - |
| EBIT Margin | 0.14 | - | - | - | - | - |
| Profit Margin | 0.14 | - | - | - | - | - |
| EBITDA | 2.76 Million | 5750.00 | - | -108 Thousand | -3.17 Million | -58 Thousand |
| Earnings Before Tax Margin | 0.14 | - | - | - | - | - |
9009
601828
300847
HCMLF
ZYME
LPRO